Study Finds Weight Loss Drugs Linked to 40% Drop in Asthma Attacks
Researchers found semaglutide was linked to nearly 40% fewer asthma attacks and a 20% drop in COPD flare-ups.
- Research presented at the European Respiratory Society Congress in Barcelona suggests semaglutide is associated with fewer asthma attacks and COPD flare-ups in patients with type 2 diabetes.
- Professor Chloe Bloom of Imperial College London led the study, analyzing UK medical records of 20,000 to 22,000 people prescribed GLP-1 therapies compared to those taking sulfonylureas.
- Data indicates semaglutide is associated with up to 40 per cent fewer asthma attacks and a 20 per cent reduction in COPD flare-ups among users.
- Experts caution the findings are observational and do not establish causation; Dr. Samantha Walker of Asthma + Lung UK warned patients should not change current asthma treatments based on these results.
- Dr. Alexander Mathioudakis of the University of Manchester noted the study highlights the need to consider metabolic health in respiratory care and supports including respiratory outcomes in future clinical trials.
74 Articles
74 Articles
Ozempic and Wegovy linked to nearly 40% fewer asthma attacks
Semaglutide, the drug found in Ozempic and Wegovy, was linked to nearly 40% fewer asthma attacks in a large real-world study. It was also associated with about 20% fewer COPD flare-ups. Researchers say GLP-1 drugs may offer respiratory benefits in addition to their effects on diabetes and obesity, but clinical trials are needed to confirm the findings.
GLP-1s May Ease Asthma Attacks, New Study Suggests
How Obesity Affects Asthma Obesity is a significant risk factor for asthma, worse asthma symptoms, and poor asthma control, according to the Centers for Disease Control and Prevention (CDC). Data suggest that nearly 39 percent of Americans with asthma also have obesity.e60dc2a1-f33c-4a05-9b50-8e3e8e597629cab4783b-b4be-4488-9e89-cc264ec94d10 “Obesity and diabetes may contribute to airway inflammation, which in turn can cause worse asthma symptoms…
Asthma, COPD Attacks Down With GLP-1 Drugs in the Picture
(MedPage Today) -- Growing evidence linked GLP-1 drugs to a reduced risk of exacerbations of two types of chronic airways disease: asthma and chronic obstructive pulmonary disease (COPD). Based on real-world records from the U.K., affected patients...
Coverage Details
Bias Distribution
- 69% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
